Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quansheng Zhou

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Frontiers of Medicine|March 31, 2012
Progress in tumor vascular normalization for anticancer therapy: challenges and perspectivesBingxue Shang, Zhifei Cao, Quansheng Zhou
Current Medicinal Chemistry|November 15, 2019
The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic CancerPing Yang, Yae Hu, Quansheng Zhou
Toxicology Letters|July 2, 2017
Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathwayPing Yang, Fulu Dong, Quansheng Zhou
Biochimica Et Biophysica Acta. Reviews on Cancer|May 2, 2021
Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapyPing Yang, Mei Meng, Quansheng Zhou
Science China. Chemistry|March 28, 2020
Multiple biological functions and pharmacological effects of lycorineZhiFei Cao, Ping Yang, QuanSheng Zhou
Frontiers in Oncology|May 16, 2022
Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung CancerPing Yang, Yingnan Qiao, Mei Meng, et al.
Biochimica Et Biophysica Acta|May 10, 2016
Recent advances in SCF ubiquitin ligase complex: Clinical implicationsNana Zheng, Quansheng Zhou, Zhiwei Wang, et al.
Current Pharmaceutical Design|December 16, 2014
Cancer/testis antigens trigger epithelial-mesenchymal transition and genesis of cancer stem-like cellsPing Yang, Zihe Huo, Huaidong Liao, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|May 18, 2012
Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer TherapyBingxue Shang, Gaochuan Zhang, Yanyan Pan, et al.
Current Cancer Drug Targets|February 17, 2016
OncomicroRNAs-Mediated Tumorigenesis: Implication in Cancer Diagnosis and Targeted TherapyNana Zheng, Ping Yang, Zhiwei Wang, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Frontiers of Medicine|March 31, 2012
Progress in tumor vascular normalization for anticancer therapy: challenges and perspectivesBingxue Shang, Zhifei Cao, Quansheng Zhou
Current Medicinal Chemistry|November 15, 2019
The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic CancerPing Yang, Yae Hu, Quansheng Zhou
Toxicology Letters|July 2, 2017
Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathwayPing Yang, Fulu Dong, Quansheng Zhou
Biochimica Et Biophysica Acta. Reviews on Cancer|May 2, 2021
Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapyPing Yang, Mei Meng, Quansheng Zhou
Science China. Chemistry|March 28, 2020
Multiple biological functions and pharmacological effects of lycorineZhiFei Cao, Ping Yang, QuanSheng Zhou
Frontiers in Oncology|May 16, 2022
Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung CancerPing Yang, Yingnan Qiao, Mei Meng, et al.
Biochimica Et Biophysica Acta|May 10, 2016
Recent advances in SCF ubiquitin ligase complex: Clinical implicationsNana Zheng, Quansheng Zhou, Zhiwei Wang, et al.
Current Pharmaceutical Design|December 16, 2014
Cancer/testis antigens trigger epithelial-mesenchymal transition and genesis of cancer stem-like cellsPing Yang, Zihe Huo, Huaidong Liao, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|May 18, 2012
Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer TherapyBingxue Shang, Gaochuan Zhang, Yanyan Pan, et al.
Current Cancer Drug Targets|February 17, 2016
OncomicroRNAs-Mediated Tumorigenesis: Implication in Cancer Diagnosis and Targeted TherapyNana Zheng, Ping Yang, Zhiwei Wang, et al.
Pageof 7